Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease

Kidney International

Volumn 76, Issue 6, 2009, Pages 629-637

  Derose, Stephen F ^a   Rutkowski, Mark P ^b   Levin, Nathan W ^c   Liu, In Lu A ^a   Shi, Jiaxiao M ^a   Jacobsen, Steven J ^a   Crooks, Peter W ^d  

^a Kaiser Permanente Southern California   (United States)

^b Baldwin Park Medical Center   (United States)

^c RENAL RESEARCH INSTITUTE   (United States)

^d Renal Program   (United States)

Author keywords

Chronic kidney disease; Epidemiology; ESRD; Minority health

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEALTH INSURANCE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SURVIVAL RATE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 69749127933     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.209     Document Type: Article

References (37)

1. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States 2007. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD.
2. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305. (Pubitemid 39268908)
3. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663. (Pubitemid 38392981)
4. Kovesdy CP, Trivedi BK, Anderson JE. Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis 2006; 13: 183-188.
5. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047. (Pubitemid 44036188)
6. Collins AJ, Li S, Gilbertson DT et al. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl 2003; 87: S24-S31. (Pubitemid 37315504)
7. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
8. Martins D, Tareen N, Norris KC. The epidemiology of end-stage renal disease among African Americans. Am J Med Sci 2002; 323: 65-71. (Pubitemid 34651556)
9. Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int 2005; 68: 914-924. (Pubitemid 43246408)
10. Krop JS, Coresh J, Chambless LE et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 1999; 159: 1777-1783. (Pubitemid 29379142)
11. Tarver-Carr ME, Powe NR, Eberhardt MS et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 2002; 13: 2363-2370.
12. Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13: I80-I93.
13. Walker WG, Neaton JD, Cutler JA et al. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 1992; 268: 3085-3091.
14. McClellan WM, Flanders WD, Langston RD et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002; 13: 1928-1936.
15. Mehrotra R, Kermah D, Fried L et al. Racial differences in mortality among those with CKD. J Am Soc Nephrol 2008; 19: 1403-1410.
16. Newsome BB, McClellan WM, Coffey CS et al. Survival advantage of black patients with kidney disease after acute myocardial infarction. Clin J Am Soc Nephrol 2006; 1: 993-999.
17. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315. (Pubitemid 38526012)
18. Levine RS, Foster JE, Fullilove RE et al. Black-white inequalities in mortality and life expectancy, 1933-1999: implications for healthy people 2010. Public Health Rep 2001; 116: 474-483.
19. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12. (Pubitemid 36043346)
20. National Institute of Diabetes & Digestive & Kidney Diseases. Chronic Renal Insufficiency Cohort (CRIC) Study. http://www.niddk.nih.gov/ patient/cric/cric.htm. 4-29-2004. Office of Communications and Public Liason, NIDDK, NIH. 9-12-2007.
21. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
22. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937.
23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39: S1-246.
24. Gao SW, Oliver DK, Das N et al. Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Clin J Am Soc Nephrol 2008; 3: 442-449.
25. Karter AJ, Ferrara A, Liu JY et al. Ethnic disparities in diabetic complications in an insured population. JAMA 2002; 287: 2519-2527. (Pubitemid 34517197)
26. National Center for Health Statistics. Health, United States, 2007: with Chartbook on Trends in the Health of Americans. US Government Printing Office: Hyattsville, Maryland, 2007.
27. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
28. Peralta CA, Shlipak MG, Fan D et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2892-2899. (Pubitemid 44484680)
29. Chen W, Petitti DB, Enger S. Limitations and potential uses of census-based data on ethnicity in a diverse community. Ann Epidemiol 2004; 14: 339-345. (Pubitemid 38737327)
30. Enger SM, Van Den Eeden SK, Sternfeld B et al. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health 2006; 6: 172. (Pubitemid 44406119)
31. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephol 2000; 11: 155A.
32. Lewis J, Agodoa L, Cheek D et al. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 2001; 38: 744-753. (Pubitemid 32927898)
33. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920-929. (Pubitemid 34454210)
34. US Department of Health & Human Services. Clinical Laboratory Improvement Amendments (CLIA). http://www.cms.hhs.gov/CLIA. 2007 11-28-2007.
35. Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007; 13: 559-565. (Pubitemid 46225362)
36. Pintilie M. Competing Risks: A Practical Perspective. John Wiley & Sons Ltd: Padstow, Cornwall, 2006.
37. Kleinbaum DG, Klein M. Survival Analysis: A Self-Learning Text. 2nd ed United States of America: Springer, 2005.